Serious and life-threatening risks from use of MS Contin: Addiction ... during initiation or following dose increases. Accidental exposure may cause fatal overdose (esp. in children).
Objective: To compare pain control, patient preference and tolerability for two extended-release formulations of morphine sulfate, Kadian ® capsules (administered once daily) and MS Contin ...
MS Contin) and oxycodone (OxyContin). These products vary in regard to their active ingredient, dosage form, mechanism of drug release, dosing frequency, pharmacokinetic profile, and cost.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results